Philips eV14-2v Transducer Wins FDA and CE Nod for OB/GYN Use

Philips has launched the Philips eV14-2v transducer. It is a transvaginal probe. The launch adds a new option to Philips' obstetrics and gynaecology ultrasound range.

The Philips eV14-2v transducer has 510(k) clearance from the US Food and Drug Administration (FDA). It also carries a CE mark. Philips said one lightweight probe covers a range of gynaecology and early obstetrics exams.

What is new in the Philips eV14-2v transducer

Philips said the eV14-2v offers a 41.7% increase in penetration. It also offers a 10% gain in 2D resolution. The field of view improves by 15.8%. The design is 22% lighter than the prior probe.

The probe uses PureWave crystal technology. The ergonomic build targets user comfort during scanning.

Clinical applications: gynaecology and early obstetrics

Philips said the probe supports visualisation of anatomy relevant to two clinical questions. The first is infertility assessment. The second is pelvic pain. Both link to conditions such as endometriosis and fibroids.

The Philips eV14-2v transducer also targets foetal work. Philips said its 2D and colour resolution can help detect foetal abnormalities. The probe can delineate cardiac chambers in a foetus as early as 13 weeks. At that stage, the foetal heart is the size of a single corn kernel.

Gannerkote on the women's health push

Philips ultrasound business leader Ajay Gannerkote framed the launch around women's health and clinician workflow.

Gannerkote said: "Advancing women's health is a priority for Philips ultrasound, and we are committed to developing innovations that make women's healthcare more accessible and more comfortable for patients."

Gannerkote added: "At Philips, we're focused on bringing together high-quality imaging, intelligent workflows and connected capabilities to simplify the ultrasound experience for clinicians and patients."

Gannerkote closed on the probe itself.

Gannerkote added: "The eV14-2v transducer reflects that approach, giving clinicians greater versatility in a single transducer and helping support high-quality care for women."

Philips Collaboration Live and broader ecosystem

The Philips eV14-2v transducer works with Philips Collaboration Live. That tool lets remote clinicians view live images. They can also offer guidance during an examination. The patient does not need to travel.

Last month, Royal Philips and Imricor Medical Systems introduced a new interventional magnetic resonance lab solution for cardiac interventions. That launch sits in a separate cardiology track, but shows Philips' wider imaging push.

Why the Philips eV14-2v transducer matters

Transvaginal ultrasound remains the workhorse probe for gynaecology and early obstetrics. Gains in penetration and field of view can shorten exams. Better 2D resolution helps early foetal cardiac work.

For obstetrics, gynaecology, and reproductive medicine teams, the Philips eV14-2v transducer is a fresh option on the shelf. For hospital procurement, the 22% weight drop and PureWave sensor are the headline changes. Coverage on Medigear.uk tracks the rollout, side-by-side comparisons with other new transvaginal probes, and Collaboration Live uptake.

Source: Originating coverage based on Medical Device Network reporting by Salong Debbarma, September 7, 2026, on Philips' launch of the eV14-2v transvaginal ultrasound transducer for obstetrics and gynaecology. URL: https://www.medicaldevice-network.com/